Security record · archived quarter
BIOA
BioAge Labs Inc. · Healthcare · Biotechnology
4Tracked holders
0Δ holders
455.40KShares held
$1.71MReported value
+2New positions
−2Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | +4 | 13.22M | $323.71M | +6 | −2 |
| Q1 2026 | 65 | +14 | 13.97M | $243.82M | +19 | −5 |
| Q4 2025 | 51 | +2 | 8.60M | $113.77M | +2 | — |
| Q3 2025 | 16 | +1 | 5.16M | $30.36M | +1 | — |
| Q2 2025 | 12 | +5 | 4.16M | $17.19M | +5 | — |
| Q1 2025 | 4 | 0 | 455.40K | $1.71M | +2 | −2 |
| Q4 2024 | 4 | -5 | 347.20K | $2.01M | +1 | −6 |
| Q3 2024 | 8 | +8 | 1.18M | $24.62M | +8 | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 282.03K | +9.7% | $1.06M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 104.83K | +121.1% | $394,161 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Marshall Wace ✦ | 53.40K | New | $200,788 | 0.0% | New | 1 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 15.14K | New | $56,945 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $200,788 | 0.0% |
| Two Sigma Investments | $56,945 | 0.0% |
Exited
| Norges Bank | $161,130 | was 0.0% |
| Millennium Management | $86,647 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 143 holders, 34.12M shares, $588.17M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API